EPO and non-small cell lung carcinoma: On the other hand, recent evidence also suggests that EPOR downregulation in NSCLC is compromised due to the lack of EPOR ubiquitination following EPO stimulation [13] and that increased pre-operative plasma EPO levels are associated with reduced survival in NSCLC patients [14].